Wednesday, 31 March 2010

Biotin Hermes




Biotin Hermes may be available in the countries listed below.


Ingredient matches for Biotin Hermes



Biotin

Biotin is reported as an ingredient of Biotin Hermes in the following countries:


  • Germany

International Drug Name Search

Saturday, 27 March 2010

Enalapril Medifarma




Enalapril Medifarma may be available in the countries listed below.


Ingredient matches for Enalapril Medifarma



Enalapril

Enalapril is reported as an ingredient of Enalapril Medifarma in the following countries:


  • Peru

International Drug Name Search

Friday, 26 March 2010

Azintamide




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0001830-32-6

Chemical Formula

C10-H14-Cl-N3-O-S

Molecular Weight

259

Therapeutic Category

Choleretic

Chemical Name

Acetamide, 2-[(6-chloro-3-pyridazinyl)thio]-N,N-diethyl-

Foreign Names

  • Azintamidum (Latin)
  • Azintamid (German)
  • Azintamide (French)
  • Azintamida (Spanish)

Generic Names

  • Azinthiamide (IS)
  • ST 9067 (IS)
  • X 23 (IS: KlingePharma)

Brand Names

  • Colerin
    Nostrum, Portugal


  • Oragalin Espasmolitico (Azintamide and Scopalamine)
    Lacer, Spain

International Drug Name Search

Glossary

ISInofficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 25 March 2010

Emergyn




Emergyn may be available in the countries listed below.


Ingredient matches for Emergyn



Levonorgestrel

Levonorgestrel is reported as an ingredient of Emergyn in the following countries:


  • Colombia

International Drug Name Search

Monday, 22 March 2010

Treximet


Treximet is a brand name of naproxen/sumatriptan, approved by the FDA in the following formulation(s):


TREXIMET (naproxen sodium; sumatriptan succinate - tablet; oral)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: April 15, 2008

    Strength(s): 500MG;EQ 85MG BASE [RLD]

Has a generic version of Treximet been approved?


No. There is currently no therapeutically equivalent version of Treximet available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Treximet. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Anti-migraine methods and compositions using 5-HT agonists with long-acting NSAIDs
    Patent 6,060,499
    Issued: May 9, 2000
    Inventor(s): Plachetka; John R.
    Assignee(s): Pozen, Inc.
    This invention comprises a method of treating migraine in a human comprising co-timely administering of a therapeutically effective amount of a 5-HT agonist coordinated with a therapeutically effective amount of an analgesic, particularly a long-acting NSAID, and in some instances, doses below those ordinarily considered as minimum effective doses as to one or both 5-HT agonist and long-acting NSAID. Dosage forms are also included herein.
    Patent expiration dates:

    • August 14, 2017
      ✓ 
      Patent use: TREATMENT OF MIGRAINE
      ✓ 
      Drug product




  • Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
    Patent 6,586,458
    Issued: July 1, 2003
    Inventor(s): John R.; Plachetka
    Assignee(s): Pozen Inc.
    The invention is directed to methods and compositions that can be used in the treatment of headaches. In particular, methods and compositions are described involving the combination of a long-acting NSAID and a 5-HT agonist. Included among the long-acting NSAIDs are cyclo-oxygenase-2 inhibitors.
    Patent expiration dates:

    • August 14, 2017
      ✓ 
      Patent use: TREATMENT OF MIGRAINE
      ✓ 
      Drug product




  • Multilayer dosage forms containing NSAIDs and triptans
    Patent 7,332,183
    Issued: February 19, 2008
    Inventor(s): Plachetka; John R. & Kothapalli; Venkata Markandeya & Gilbert; Donna L.
    Assignee(s): Pozen Inc.
    The present invention is directed to multilayer pharmaceutical tablets in which an NSAID and a triptan are present in separate and distinct layers. The layers are in a side-by-side configuration, which allows the dissolution of triptan and NSAID to occur independently and immediately.
    Patent expiration dates:

    • October 2, 2025
      ✓ 
      Patent use: TREATMENT OF MIGRAINE
      ✓ 
      Drug product




  • Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
    Patent 8,022,095
    Issued: September 20, 2011
    Inventor(s): Plachetka; John R.
    Assignee(s): Pozen, Inc.
    The invention is directed to methods and compositions that can be used in the treatment of headaches. In particular, methods and compositions are described involving the combination of a long-acting NSAID and a 5-HT1B/1D agonist.
    Patent expiration dates:

    • August 14, 2017
      ✓ 
      Patent use: TREATMENT OF MIGRAINE
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • April 15, 2011 - NEW COMBINATION

See also...

  • Treximet Consumer Information (Drugs.com)
  • Treximet Consumer Information (Wolters Kluwer)
  • Treximet Consumer Information (Cerner Multum)
  • Treximet Advanced Consumer Information (Micromedex)
  • Sumatriptan/Naproxen Consumer Information (Wolters Kluwer)
  • Sumatriptan and naproxen Consumer Information (Cerner Multum)
  • Sumatriptan and naproxen Advanced Consumer Information (Micromedex)

ratio-Morphine SR




ratio-Morphine SR may be available in the countries listed below.


Ingredient matches for ratio-Morphine SR



Morphine

Morphine sulphate pentahydrate (a derivative of Morphine) is reported as an ingredient of ratio-Morphine SR in the following countries:


  • Canada

International Drug Name Search

Friday, 19 March 2010

Amikavet




Amikavet may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Amikavet



Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Amikavet in the following countries:


  • Italy

International Drug Name Search

Thursday, 11 March 2010

Propranolol Ecar




Propranolol Ecar may be available in the countries listed below.


Ingredient matches for Propranolol Ecar



Propranolol

Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Propranolol Ecar in the following countries:


  • Colombia

International Drug Name Search

Wednesday, 10 March 2010

Iodio Sella




Iodio Sella may be available in the countries listed below.


Ingredient matches for Iodio Sella



Iodine

Iodine is reported as an ingredient of Iodio Sella in the following countries:


  • Italy

Potassium Iodide

Potassium Iodide is reported as an ingredient of Iodio Sella in the following countries:


  • Italy

International Drug Name Search

Tuesday, 9 March 2010

Chetotifene Mylan




Chetotifene Mylan may be available in the countries listed below.


Ingredient matches for Chetotifene Mylan



Ketotifen

Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Chetotifene Mylan in the following countries:


  • Italy

International Drug Name Search

Thursday, 4 March 2010

Apracal




Apracal may be available in the countries listed below.


Ingredient matches for Apracal



Haloperidol

Haloperidol is reported as an ingredient of Apracal in the following countries:


  • Colombia

International Drug Name Search

Wednesday, 3 March 2010

Ampigen SB




Ampigen SB may be available in the countries listed below.


Ingredient matches for Ampigen SB



Ampicillin

Ampicillin sodium salt (a derivative of Ampicillin) is reported as an ingredient of Ampigen SB in the following countries:


  • Argentina

Sulbactam

Sulbactam sodium salt (a derivative of Sulbactam) is reported as an ingredient of Ampigen SB in the following countries:


  • Argentina

Sultamicillin

Sultamicillin tosilate (a derivative of Sultamicillin) is reported as an ingredient of Ampigen SB in the following countries:


  • Argentina

International Drug Name Search

Tuesday, 2 March 2010

Predni H Tablinen




Predni H Tablinen may be available in the countries listed below.


Ingredient matches for Predni H Tablinen



Prednisolone

Prednisolone is reported as an ingredient of Predni H Tablinen in the following countries:


  • Germany

International Drug Name Search